Anti-FATE1 antibody
英文名称 | FATE1 |
中文名称 | FATE1蛋白抗体 |
别 名 | Cancer/testis antigen 43; CT43; FATE; FATE1; FATE1_HUMAN; fetal and adult testis expressed 1; fetal and adult testis expressed transcript protein; Fetal and adult testis-expressed transcript protein; Protein BJ HCC 2; Tumor antigen |
DATASHEET
Host:Rabbit
Target Protein:FATE1
IR:Immunogen Range:1-100/183
Clonality:Polyclonal
Isotype:IgG
Entrez Gene:89885
Swiss Prot:Q969F0
Source:KLH conjugated synthetic peptide derived from human FATE1:1-100/183
Purification:affinity purified by Protein A
Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Background:FATE1 (fetal and adult testis expressed 1), also known as FATE, CT43 (cancer/testis antigen 43) or BJ-HCC-2, is a cancer/testis antigen found in testis and tumor tissues (specifically hepatocarcinoma cells). Its expression is regulated by SF-1 (Steroidogenic Factor 1) and WT1 (Wilms’ tumor protein), two proteins involved in tumorigenesis, suggesting a role for FATE1 in tumor development. FATE1 is exclusively expressed in testis of the 6-11 week old fetus (around the period of gonadal sex differentiation). At 7 weeks, FATE1 is coexpressed with SRY and may play a role in early testicular differentiation. In adults, although predominantly expressed in testis, FATE1 can also be found in heart, kidney, brain, lung and adrenal gland. Mutations in the gene encoding FATE1 may be contributing factors in male infertility.
Size:100ul
Concentration:1mg/ml
Applications:
Cross Reactive Species:Human
.
For research use only. Not intended for diagnostic or therapeutic use.
好评度